(MT Newswires) -- Moderna Inc. co-founder and Chairman Noubar Afeyan talks about the state of the biotechnology industry and the challenges it faces. He also discusses the vaccine maker's strategy, and how the industry can utilize artificial intelligence. He speaks with Francine Lacqua on the sidelines of the New Economy Forum in Singapore.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
123.9 USD | +5.63% | +0.85% | +23.85% |
09:45am | Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing | MT |
May. 10 | Equities Mostly Rise as Traders Parse Fed Officials' Comments, Consumer Sentiment Survey | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.85% | 44.96B | |
+0.96% | 42.65B | |
+46.06% | 41.85B | |
-4.27% | 29.04B | |
+10.61% | 26.08B | |
-20.72% | 19.03B | |
+5.54% | 12.75B | |
+28.14% | 12.06B | |
-4.08% | 11.75B | |
+21.47% | 11.72B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Moderna Chairman Afeyan on Industry Outlook, Strategy, AI